PI
ARKG icon

PEAK6 Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

PEAK6 Investments’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-63,403
Closed -$2.91M – 6081
2022
Q1 		$2.91M Buy
63,403
+43,798
+223% +$2.09M 0.01% 1530
2021
Q4 		$1.2M Sell
19,605
-117,607
-86% -$8.13M ﹤0.01% 2395
2021
Q3 		$10.3M Buy
+137,212
New +$11.5M 0.02% 691
2021
Q2 		– Sell
-210,917
Closed -$17.9M – 5089
2021
Q1 		$18.7M Buy
210,917
+110,522
+110% +$11M 0.05% 372
2020
Q4 		$9.36M Buy
+100,395
New +$8M 0.02% 699

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

PEAK6 Investments's ARKG Position: Q2 2022 in Review

PEAK6 Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2022, closing a stake of 63,403 shares — an estimated $2.91M sold.

PEAK6 Investments first reported a position in ARKG in Q4 2020 and held it in 5 quarters. The position peaked at $18.7M in Q1 2021. 333 funds tracked by Wall St. Rank hold ARKG as of Q2 2022.

  • PEAK6 Investments reported no remaining ARK Genomic Revolution ETF position as of Q2 2022 after selling out during the quarter.
  • PEAK6 Investments sold 63,403 ARK Genomic Revolution ETF shares in Q2 2022, an estimated $2.91M.
  • PEAK6 Investments first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 5 quarters.
  • PEAK6 Investments's ARK Genomic Revolution ETF position peaked at $18.7M in Q1 2021.
  • 333 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2022.

Based on PEAK6 Investments's 13F filing for Q2 2022, filed 12 Aug 2022.